Modeling the adoption of urban air mobility based on technology acceptance and risk perception theories: A case study on flying cars
Multimodal Transportation · 2025-06 · 4 (2) · 100200
DOI: 10.1016/j.multra.2025.100200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multimodal Transportation, 2025-06. Verfasst von Sangen Hu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Office of Philosophy and Social Science, Ministry of Education of the People's Republic of China, Guangzhou Municipal Science and Technology Project.
Themen: Mobilisation
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Anhui Office of Philosophy and Social Science
- Ministry of Education of the People's Republic of China
- Guangzhou Municipal Science and Technology Project
- South China University of Technology
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong University of Technology
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Hu, S., Huang, Z., Wang, K., Lin, H., & Pei, M. (2025). Modeling the adoption of urban air mobility based on technology acceptance and risk perception theories: A case study on flying cars. Multimodal Transportation, 4(2), 100200. https://doi.org/10.1016/j.multra.2025.100200
Vancouver
Hu S, Huang Z, Wang K, Lin H, Pei M. Modeling the adoption of urban air mobility based on technology acceptance and risk perception theories: A case study on flying cars. Multimodal Transportation. 2025;4(2):100200. doi:10.1016/j.multra.2025.100200
BibTeX
@article{Hu2025,
author = {Hu, Sangen and Huang, Zikang and Wang, Ke and Lin, Haiyuan and Pei, Mingyang},
title = {Modeling the adoption of urban air mobility based on technology acceptance and risk perception theories: A case study on flying cars},
journal = {Multimodal Transportation},
year = {2025},
volume = {4},
number = {2},
pages = {100200},
doi = {10.1016/j.multra.2025.100200}
}
EUVIMED